| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 4,700,341 | 4,700,341 |
| Net increase in cash | 2,723,953 | 3,315,337 |
| Cash and cash equivalents at beginning of period | 3,325,131 | - |
| Cash and cash equivalents at end of period | 6,049,084 | - |
Bone Biologics Corp (BBLG)
Bone Biologics Corp (BBLG)